NCT03880253View on ClinicalTrials.gov

Multiple Ascending Dose Study of CTP-692 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 10, 2019

Primary Completion Date

May 16, 2019

Study Completion Date

May 16, 2019

Conditions
Healthy
Interventions
DRUG

CTP-692

Placebo or CTP-692

Trial Locations (1)

90806

Collaborative Neuroscience Network, LLC, Long Beach

Sponsors
All Listed Sponsors
lead

Concert Pharmaceuticals

INDUSTRY